-

MedMen Opens Coral Shores Location in Florida

LOS ANGELES--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQB: MMNFF) is pleased to announce today the opening of its Coral Shores location near Fort Lauderdale, Florida. MedMen Coral Shores is the Company’s fifth operational location in the state. MedMen Coral Shores is located at 2949 North Federal Highway, occupying 1,668 square feet of retail space.

MedMen Coral Shares will offer a robust selection of high-quality products including house brands, MedMen, [statemade] and Luxlyte. MedMen Coral Shores will open with a full inventory of vapes, pre-rolls and flower, which will be available in-store or through the Company’s proprietary online ordering service for all patients and Buds rewards members.

MedMen: The Company’s signature house brand in Florida is the intersection of quality and value, featuring custom-formulated solutions in accessible, easy-to-use forms including flower, pre-rolls and vapes.

[statemade]: The product line provides consumers with high-quality cannabis products made in their own state. The products will include vapes and tinctures across five different effects.

LuxLyte: The LuxLyte brand features five precise CBD to THC ratio-based formulas across vapes, sprays, drops, capsules and lotions. LuxLyte provides easy-to-understand solutions made from high-quality cannabis.

To learn more, please visit Ember, MedMen’s digital editorial platform, at www.medmen.com/blog.

ABOUT MEDMEN:

MedMen is North America’s leading cannabis retailer with flagship locations in Los Angeles, Las Vegas, Chicago, and New York. MedMen offers a robust selection of high-quality products, including MedMen-owned brands [statemade], LuxLyte, and MedMen Red through its premium retail stores, proprietary delivery service, as well as curbside and in-store pick up. MedMen Buds, an industry-first loyalty program, provides exclusive access to promotions, product drops and content. MedMen believes that a world where cannabis is legal and regulated is safer, healthier and happier. Learn more about MedMen and The MedMen Foundation at www.medmen.com

SOURCE: MedMen Enterprises

Contacts

MEDIA:
Julian Labagh
Director of Consumer Communications
Email: julian.labagh@medmen.com
IG: @shopmedmen
Tw: @medmen

INVESTORS:
Zeeshan Hyder
Chief Financial Officer
Email: investors@medmen.com

MedMen Enterprises

CNSX:MMEN

Release Summary
Coral shores opening
Release Versions

Contacts

MEDIA:
Julian Labagh
Director of Consumer Communications
Email: julian.labagh@medmen.com
IG: @shopmedmen
Tw: @medmen

INVESTORS:
Zeeshan Hyder
Chief Financial Officer
Email: investors@medmen.com

More News From MedMen Enterprises

MedMen Announces Management and Board Changes

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company, today announced that Ellen Deutsch Harrison has stepped down as the Chief Executive Officer and a Board member effective January 19, 2024 and the Board has appointed Richard Ormond as Chief Restructuring Officer. Furthermore, Michael Serruya, Executive Chairman of the Board, who has served on the Board since August 2021, has stepped down from the Board e...

MedMen Exits Arizona Market, Completing Sale of Local Operations to MINT Cannabis

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, today announced that the Company has completed the previously announced sale of its non-core business operations in Arizona to an affiliate of Mint Cannabis (“MINT Cannabis”). The pending sale of the Company’s assets in Nevada to MINT Cannabis awaits regulatory approval for completion. “We are pleased to announce...

MedMen Provides Annual Filing Status Report

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, is providing this bi-weekly default status report in accordance with National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"). On November 2, 2023, the Company announced that it had been granted a management cease trade order against the Company’s CEO and CFO (“MCTO”) by its principal regulator, the Br...
Back to Newsroom